Gestational diabetes malpractice lawsuits arise when healthcare providers fail to diagnose, screen for, or properly manage gestational diabetes during pregnancy, resulting in serious birth injuries or fetal complications. These lawsuits typically involve obstetricians, midwives, or obstetric nurses who breach the accepted standard of care by either missing the diagnosis entirely or failing to monitor and treat the condition once identified. For example, in a 2025 Wisconsin verdict, a certified nurse-midwife’s failure to escalate care when fetal heart rate dropped to dangerously low levels—combined with delayed contact with an obstetrician—resulted in a $29 million judgment after the child developed cerebral palsy.
Gestational diabetes cases represent a growing category of birth injury litigation. Between 2016 and 2024, gestational diabetes incidence increased 36%, rising from 6.0% to 8.3% of pregnant women, and cases now affect approximately 81 per 1,000 live births. This rising prevalence, combined with clearly established standards of care for screening and management, has created a distinct legal landscape where undiagnosed or mismanaged gestational diabetes frequently forms the foundation of malpractice claims.
Table of Contents
- Why Is Gestational Diabetes Screening a Standard of Care?
- How Does Unmanaged Gestational Diabetes Lead to Birth Injuries?
- What Do Recent Court Verdicts Reveal About Gestational Diabetes Malpractice Cases?
- What Are the Two Categories of Gestational Diabetes Malpractice?
- What Complications Develop When Gestational Diabetes Is Inadequately Treated?
- How Are Treatment Standards Changing with Continuous Glucose Monitoring?
- What Should Pregnant Women Do If They Suspect Gestational Diabetes Mismanagement?
- Conclusion
Why Is Gestational Diabetes Screening a Standard of Care?
Testing for gestational diabetes during pregnancy is now universally accepted as the standard of care. The American College of Obstetricians and Gynecologists (ACOG) recommends screening between 24 and 28 weeks of gestation using a glucose tolerance test. Failure to perform this screening—or failure to follow up on abnormal results—constitutes a clear breach of the duty owed to the patient. Healthcare providers who skip or delay gestational diabetes screening, particularly in high-risk populations, face substantial liability exposure in malpractice cases.
The condition disproportionately affects certain populations. American Indian and Alaska Native women, Asian women, and Native Hawaiian and Pacific Islander women experience the highest prevalence rates of gestational diabetes. These disparities mean that providers have heightened obligations to screen these patient populations carefully and, when gestational diabetes is detected, to manage it aggressively. A provider’s failure to recognize a patient’s higher-risk status compounds the negligence.
How Does Unmanaged Gestational Diabetes Lead to Birth Injuries?
When gestational diabetes goes undiagnosed or is inadequately managed, the consequences for the fetus are severe. The most common complication is macrosomia—excessive fetal growth due to maternal hyperglycemia—which occurs in approximately 50% of gestational diabetes cases, compared to just 9% in the general pregnant population. This dramatic 5-fold increase in risk demonstrates why proper management is critical. Macrosomia itself creates the conditions for traumatic birth injuries.
When a baby is significantly larger than expected, the delivery process becomes extraordinarily difficult. The baby’s shoulders can become lodged behind the mother’s pubic bone during delivery—a condition called shoulder dystocia—which can result in clavicular fractures, brachial plexus injuries, and permanent nerve damage causing Erb’s palsy or Klumpke’s paralysis. Even with prompt management, these injuries can cause lifelong disability including loss of arm function, chronic pain, and developmental delays. The limitation here is that even with proper care, some cases of shoulder dystocia result in injury, but with negligent management, the risk multiplies significantly.
What Do Recent Court Verdicts Reveal About Gestational Diabetes Malpractice Cases?
The courts have consistently awarded substantial damages in gestational diabetes cases. A 2023 Georgia verdict of $30 million involved a patient with both gestational diabetes and preeclampsia whose fetal monitor was displaced during labor, causing an amniotic fluid embolism that deprived the infant of oxygen and resulted in severe brain injury. This case illustrates how complications of gestational diabetes can interact with other maternal conditions to create catastrophic outcomes when not properly monitored.
A 2023 Pennsylvania case resulted in a $16 million verdict where obstetricians detected fetal distress but failed to conduct further evaluations or take appropriate action, resulting in a stillbirth. In 2024, a Michigan case settled for $8 million involving a 29-year-old gestational diabetic mother who delivered at 38 weeks and 6 days—a timeline that suggests inadequate fetal monitoring or concern about fetal viability. New York cases have produced settlements exceeding $5.7 million when obstetrical care was negligent, the gestational diabetes history was missed, and fetal distress went unrecognized, leading to hypoxic ischemic brain injury and seizure disorders. These verdicts demonstrate that courts recognize the causative link between gestational diabetes mismanagement and catastrophic fetal harm.
What Are the Two Categories of Gestational Diabetes Malpractice?
Medical malpractice related to gestational diabetes falls into two distinct categories: failure to diagnose and mismanagement of the diagnosed condition. The first category involves providers who never order gestational diabetes screening, or who receive abnormal test results but fail to inform the patient or pursue follow-up testing.
The second category involves providers who correctly diagnose gestational diabetes but then fail to implement adequate management—including inadequate fetal monitoring, failure to counsel on diet and exercise, failure to prescribe necessary medications, or failure to escalate care when glucose levels remain uncontrolled. To succeed in a gestational diabetes malpractice lawsuit, a plaintiff must establish four legal elements: the healthcare provider owed a duty of care to the patient, the provider breached that duty by departing from accepted standards of care, the breach directly caused harm to the patient or fetus, and the plaintiff suffered actual damages. Because the standard of care for gestational diabetes screening is so well-established, proving the first three elements is often straightforward—the breach is clear, the causation is demonstrable (particularly when macrosomia or birth injury follows), and damages in birth injury cases are substantial.
What Complications Develop When Gestational Diabetes Is Inadequately Treated?
One critical warning: approximately 30% of women with gestational diabetes cannot achieve adequate glucose control through diet and lifestyle modifications alone and require pharmacological treatment, typically insulin injections. Providers who diagnose gestational diabetes but decline to prescribe insulin when dietary management fails are committing malpractice. The patient’s inability to control blood sugar through behavior alone is not a reason to avoid medication—it is a reason to escalate treatment.
Failure to prescribe necessary insulin often precedes the most severe fetal complications. Beyond macrosomia and shoulder dystocia, uncontrolled gestational diabetes leads to other serious complications including preeclampsia (pregnancy-induced high blood pressure), premature delivery, stillbirth, and neonatal hypoglycemia and hypocalcemia. These conditions frequently require NICU admission and can result in cerebral palsy, developmental delays, cognitive impairment, and lifelong disability. A 2025 New York settlement of $1 million involved a stillborn child born to a gestational diabetic mother whose condition was not properly managed—illustrating that even in the lower-settlement cases, the outcomes are catastrophic.
How Are Treatment Standards Changing with Continuous Glucose Monitoring?
Recent advances in gestational diabetes management have established new benchmarks for standard care. Continuous glucose monitoring (CGM) systems—which track glucose levels in real-time throughout the day—have demonstrated superior outcomes compared to traditional finger-stick blood glucose monitoring.
According to 2025 World Health Organization guidelines, CGM use in gestational diabetes management results in fewer unscheduled cesarean sections, fewer preterm deliveries, lower rates of large-for-gestational-age births, and importantly, lower neonatal intensive care unit (NICU) admissions. These improvements matter for future malpractice litigation because they establish that providers who fail to offer or implement CGM technology in appropriate cases may be breaching the standard of care. As these technologies become more accessible and their benefits more clearly demonstrated, expectations for their use will increase, and litigation will follow for providers who do not adopt them.
What Should Pregnant Women Do If They Suspect Gestational Diabetes Mismanagement?
Pregnant women should insist on gestational diabetes screening at the appropriate gestational age and should understand their risk factors—particularly if they belong to a high-prevalence population. If diagnosed with gestational diabetes, patients should expect close fetal monitoring (including non-stress tests), dietary counseling, blood glucose monitoring, and pharmacological treatment if needed.
They should also question any provider who minimizes the condition or resists treating it aggressively. Looking forward, the rising incidence of gestational diabetes combined with increasingly sophisticated management tools and established legal standards means that malpractice cases in this area will likely continue to expand. Healthcare systems that fail to invest in proper screening protocols, adequate fetal monitoring technology, and access to maternal-fetal medicine specialists create liability for themselves and harm for patients.
Conclusion
Gestational diabetes malpractice lawsuits address a critical gap between accepted standards of care and the reality of what occurs in some clinical settings. The condition is common, its diagnosis is straightforward, its management is well-established, and the consequences of failure are profound and well-documented in the medical literature.
Courts have consistently awarded substantial damages—ranging from $1 million to $30 million—in cases where providers failed to screen, diagnose, or adequately treat gestational diabetes. If you or a family member suffered a birth injury following gestational diabetes that was missed or mismanaged, a consultation with a birth injury malpractice attorney is warranted. These cases require expert medical testimony to establish the standard of care and the causal link between the provider’s negligence and the child’s injury, but the medical and legal foundations for such claims are well-established and have repeatedly succeeded in securing compensation for families.